¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Minimal residual disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® Raynaud disease ÇÑ±Û ·¹À̳뺴
¼³¸í   
  ±â´ÉÀû Ç÷°ü °æ·ÃÀ» ÀÏÀ¸Å°´Â º´À¸·Î °Ç°­ÇÑ ÀþÀº ¿©¼ºÀÇ ÆÈ´Ù¸® ÀÛÀº µ¿¸ÆÀ» Ä§¹üÇÑ´Ù. ÇÁ¶û½º ÀÇ»ç M.·¹À̳ë(1834~1881)°¡ º¸°íÇÑ °ÍÀ¸·Î ÀÌ º´Àº ÁַΠ¼Õ°¡¶ô, ¼Õ, ¶§·Î´Â ÄÚ³¡À̳ª ¹ßµî, ¸öÀÇ ¸»´ÜºÎ ¼Òµ¿¸ÆÀ» Ä§¹üÇÑ´Ù. Çѳðú °¨Á¤Àڱؿ¡ ÀÇÇϸ砼հ¡¶ôÀº ¹é»öÀ¸·Î ´ÙÀ½Àº Ã»»öÀ¸·Î, ±×¸®°í Àû»öÀ¸·Î º¯ÇÑ´Ù. ¿©¼º¿¡°Ô È£¹ßÇÑ´Ù.
¿µ¹® rheumatic heart disease ÇÑ±Û ·ù¸¶Æ¼½º½ÉÀ庴
¼³¸í   
  »ç½½¾Ë±Õ°¨¿° ÈÄ »ý±â´Â ½ÉÀåÆÇ¸·º´ÀÌ´Ù. ¿øÀÎÀº A±º -¿ëÇ÷»ç½½¾Ë¿¡ ÀÇÇÑ Àεο°ÈÄ ÀÏÁ¾ÀÇ ¸é¿ª¹ÝÀÀÀ¸·Î ¹ßº´ÇÑ´Ù.
  
  Áø´ÜÀº Á¸ÀÇ ±âÁØ¿¡ ÀÇÇÑ´Ù.
  
  (1) ÁÖ¿ä±âÁØÀº °üÀý¿° ½ÉÀå¿°(½ÉÀåºñ´ë, ½ÉÀåÀâÀ½, ½ÉÀå±â´É»ó½Ç µî) ¹«µµÁõ: ¹«´çÀÌ ÃãÀ» Ãߴ °Í °°Àº ÇൿÀÇ ¹ßÀÛÁõ¼¼. ¿¬º¯È«¹Ý: »¡°£ Å׵θ®¸¦ °¡Áø ÇǺκ´º¯Àº ÇÇÇϰáÀý(subcutaneous nodule): ÇǺΠ¹Ø¿¡ »ý±ä °áÀý,
  
  (2)Âü°í ±âÁØÀº ¿­, °üÀýÅë, EKG»ó PR¿¬Àå: ½ÉÀüµµ ¼Ò°ß ±Þ¼º±â ¹ÝÀÀ¹°Áú(¿¹: ESR, CRP)ÀÇ »ó½Â, ·ù¸¶Æ¼½º¿­
  
  Ä¡·á´Â Æä´Ï½Ç¸°À¸·Î Ä¡·áÇÏ°í ½ÉÀåÀÇ ÈÄÀ¯Áõ ¶ÇÇÑ Æä´Ï½Ç¸°À¸·Î ¿¹¹æÇÑ´Ù.
¿µ¹® chronic obstructive pulmonary disease ÇÑ±Û ¸¸¼ºÆó¼âÆóº´
¼³¸í   
  ¸¸¼ºÀûÀ¸·Î ±âµµÀÇ Æó¼â¸¦ °¡Á®¿À´Â º´À» À̸£´Â ¸». ´ë°³ ¸¸¼º±â°üÁö¿°, ±â°üÁö Ãµ½Ä, Æó±âÁ¾ÀÇ 3°¡Áö º´À» ¸»ÇÑ´Ù.
  
  ¸¸¼º±â°üÁö¿°À̶õ ±â°üÁöÀÇ ¸¸¼º¿°ÁõÀ» ¸»ÇÑ´Ù. ±â°üÁöÀÇ ¿°ÁõÀ¸·Î ÀÎÇØ¼­ ±â°üÁöÀÇ Á¡¸·¿¡ ºÎÁ¾ÀÌ »ý±â°í À̷ΠÀÎÇØ¼­ ±â°üÁöÀÇ ³»°æÀÌ Á¼¾ÆÁ®¼­ ±âµµÀÇ Æó¼â¸¦ °¡Á®¿Â´Ù. ´ë°³ Èí¿¬°ú ¹ÐÁ¢ÇÑ ¿¬°üÀ» °¡Áö¸ç, È£Èí°ï¶õ, ±âħ, ±×¸®°í °¡·¡(´ë°³ »öÀ̠Ǫ¸£°í Á¡µµ°¡ ³ôÀº °¡·¡)°¡ Áõ»óÀ¸·Î ³ªÅ¸³­´Ù.
  
  Æó±âÁ¾Àº ±â°üÁöÀÇ º®À» ÁöÁöÇϴ Á¶Á÷ÀÇ ÆÄ±«¿¡ ÀÇÇØ¼­ ±â°üÁö°¡ Á¦ ¸ð¾çÀ» °®ÃßÁö ¸øÇÏ°í ¹«³ÊÁö°Ô µÇ¾î ±âµµÀÇ Æó¼â°¡ ÀϾ´Â º´ÀÌ´Ù. Áï ±â°üÁö°¡ °ü ¸ð¾çÀ¸·Î ÆØÆØÇϰԠÆìÁö´Â °ÍÀ» ÁöÁöÇϴ Á¶Á÷ÀÇ ÆÄ±«¿¡ ÀÇÇØ¼­ °ü¸ð¾çÀ¸·Î ÆìÁöÁö ¸øÇØ °á±¹Àº ÆóÆ÷³»¿¡ °ø±â°¡ Â÷°í ÆóÆ÷º®ÀÌ ÆÄ¿­µÇ°í ±â°üÁö°¡ Á¼¾ÆÁö°Ô µÇ´Â º´À» ¸»ÇÑ´Ù.
  
  ±â°üÁöõ½ÄÀ̶õ ¿©·¯ °¡Áö Àڱؿ¡ ´ëÇØ¼­ ±â°üÁö°¡ °ú¹ÎÇÑ ¹ÝÀÀÀ» º¸¿©¼­ »ý±â´Â ±â°üÁöÀÇ °¡¿ªÀûÀΠÆó¼â¸¦ ÀǹÌÇÑ´Ù. Áï Á¤»óÀο¡°Ô¼­´Â ±â°üÁöÀÇ Æó¼â¸¦ º¸ÀÌÁö ¾Ê´Â Àڱؿ¡ ´ëÇØ¼­ ±â°üÁöÀÇ Æó¼â°¡ »ý±â°í ±× ÀÚ±ØÀÌ ¾øÀ» °æ¿ì¿¡´Â ±â°üÁöÀÇ Æó¼â°¡ ¾ø¾îÁö´Â º´À» ¸»ÇÑ´Ù. 
¿µ¹® Buerger disease ÇÑ±Û ¹ö°Åº´
¼³¸í   
  ¸»ÃÊ µ¿¸Æ°ú Á¤¸Æ¿¡ ¿°ÁõÀ» ÀÏÀ¸Å°´Â º´. Ã»Àå³âÃþÀÇ ³²ÀÚ¿¡°Ô Àß °É¸®´Â ´Ù¸® µ¿¸Æ¿¡ »ý±â´Â º´À¸·Î µ¿¸ÆÀÌ ¸·È÷°í ÅëÁõ ¶§¹®¿¡ ¹ßÀ» Àý±âµµ Çϴµ¥ ¿øÀÎÀº ¾Ë·ÁÁ® ÀÖÁö ¾Ê´Ù. º´¸íÀº ÀÌ º´À» ÃÖÃʷΠ»ó¼¼ÇϰԠº¸°íÇÑ ¹Ì±¹ÀÇ ÀÇ»ç L. ¹ö°Å(1879~1943)ÀÇ À̸§¿¡¼­ ¿¬À¯ÇÑ´Ù. µ¿¾çÀο¡°Ô ¸¹Àº º´À¸·Î, ´ëºÎºÐ ÀþÀº ³²¼º, Æ¯È÷ Àå³â±â ³²¼º¿¡°Ô¼­ ³ªÅ¸³­´Ù. ¿øÀÎÀº ¾Ë ¼ö ¾øÀ¸³ª Èí¿¬ÀÌ º´ÀÇ ¾ÇÈ­¸¦ ÃÊ·¡ÇÑ´Ù. »çÁöÀÇ µ¿¸Æ°ú Á¤¸Æ¿¡ ¿°ÁõÀÌ ÀϾ Ç÷ÀüÀÌ »ý±â¸é ³»°­À» ¸·¾Æ Ç÷¾×ÀÌ È帣Áö ¸øÇϰԠµÇ¾î ±× ¾ÕÀÇ ¸»ÃÊÁ¶Á÷ÀÌ ±«»ç¿¡ ºüÁö°Å³ª ¼Õ¹ßÀÌ Â÷°©°í, ¼Õ°¡¶ô-¹ß°¡¶ôÀÌ º¸¶ó»ö ¶Ç´Â °ËÀº»öÀ¸·Î º¯ÇÑ´Ù. ¶Ç, ÀÌ Áõ¼¼°¡ °è¼ÓµÇ´Â µ¿¾È ¼Õ¹ß°¡¶ô¿¡ ÅëÁõÀÌ ÀϾ°í ±Ë¾çÀÌ ¹ß»ýÇÑ´Ù. Ä¡·á´Â Áõ¼¼ÀÇ Á¤µµ¿Í Æó»öµÈ Ç÷°üÀÇ ºÎÀ§¿¡ µû¶ó ¿¬°í¸¦ ¹Ù¸£°Å³ª Ç÷°üÈ®ÀåÁ¦-¼øÈ¯°³¼±Á¦-Ç÷¼ÒÆÇÀÀÁý¾ïÁ¦Á¦¸¦ »ç¿ëÇϳª, ¾î¶² Ä¡·áµµ È¿°ú°¡ ¾øÀ» °æ¿ì ¼Õ¹ß°¡¶ôÀÇ ¼ÒÀý´Ü, µå¹°°Ô´Â ¹«¸­ ÀÌÇÏÀÇ ´ëÀý´ÜÀ» ÇؾߠÇÑ´Ù. ÀϹÝÀûÀ¸·Î ÀÌ º´ÀÇ ¿¹ÈĴ ¾çÈ£ÇÏ¿© Ç÷·ù°¡ È¸º¹µÇ°í ±Ë¾ç¸¸ Ä¡·áµÇ¸é Àç¹ßÀÌ Àû´Ù.
¿µ¹® Behcet disease ÇÑ±Û º£Ã¼Æ®º´
¼³¸í   
  ½ÉÇÑ Æ÷µµ¸·¿°, ¸Á¸·Ç÷°ü¿°, ½Ã°¢½Å°æÀ§Ãà, ±¸°­-¼º±âÀÇ ¾ÆÇÁŸ¼º ±Ë¾ç, ±¤¹üÀ§ÇÑ Ç÷°ü¿°ÀǠ¡ÈĿ͠Áõ»óÀ» ³ªÅ¸³½´Ù. ¿øÀκҸíÀÇ Èñ±ÍÇÑ º´À¸·Î ÀþÀº ³²ÀÚ¿¡°Ô Àß ¹ß»ýÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • minimal lethal dose
    1. ÃÖ¼ÒÄ¡»ç·® 2. ÃÖ¼ÒÄ¡»ç¼±·®
  • minimal stimulus
    ÃÖ¼ÒÀÚ±Ø
  • minimal tension line
    ÃÖ¼ÒÀå·Â¼±
  • minimal visible angle
    Ãּҽð¢
  • minimal volition period
    ÃÖ¼Ò¼öÃà±â
  • functional residual air
    ±â´ÉÀûÀܱâ
  • functional residual capacity
    ±â´ÉÀܱâ¿ë·®
  • residual
    1. ÀÜ·ù- 2. ÀÜ¿©-, ÀÜÁ¸- 3. ÈÄÀ¯-
  • residual abscess
    ÀÜ·ù°í¸§Áý, ÀÜ·ù³ó¾ç
  • residual accommodation
    ÀÜ¿©Á¶Àý
  • residual antigen
    ÀÜ·ùÇ׿ø
  • residual astigmatism
    ÀÜÁ¸³­½Ã
  • residual chlorine
    ÀÜ·ù¿°¼Ò
  • residual chromatin
    ÀÜ¿©¿°»öÁú
  • residual current
    ÀÜ·ùÀü·ù
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • de Quervain's disease
    µåÄõº£Àκ´
  • degenerative disease
    ÅðÇິ
  • fibrocystic disease
    ¼¶À¯³¶º´
  • glomerular disease
    Å丮º´, »ç±¸Ã¼Áúȯ
  • Hashimoto's disease
    ÇϽøðÅ亴
  • Hirschsprung's disease
    (¢¡ congenital megacolon) È÷¸£½´½´ÇÁ·îº´
  • hyaline membrane disease
    À¯¸®Áú¸·º´
  • infectious disease
    °¨¿°º´
  • inflammatory bowel disease
    ¿°ÁõâÀÚÁúȯ
  • inherited disease
    À¯Àüº´
  • Legg-Calve-Perthes disease
    (¢¡ostetochondrosis of the capitualar epiphysis of th) ·¹±×Ä®º£Æä¸£Å×½ºº´, ³Ò´Ù¸®»À¸Ó¸®»À³¡»À¿¬°ñÁõ
  • life style disease
    »ýȰ½À°üº´
  • metabolic disease
    ´ë»çº´, ´ë»çÁúȯ
  • mixed connective tissue disease
    È¥ÇÕ°áÇÕÁ¶Á÷º´
  • moyamoya disease
    ¸ð¾ß¸ð¾ßº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • minimal stimulus
    ÃÖ¼ÒÀÚ±Ø
  • minimal angle resolution
    ÃÖ¼Ò°¢ºÐÇØ´É
  • minimal daily requirement
    ÃÖ¼Ò¿µ¾çÇʿ䷮, ÃÖ¼ÒÀÏÀϿ䱸·®
  • minimal identifiable odor
    ÃÖ¼ÒºÐÇØÃë°¢, ÃÖ¼ÒÀνij¿»õ
  • minimal nerve excitability test
    ÃּҽŰæÀڱذ˻ç
  • minimal stimulating test
    ¹Ì¾àÁÖÀÔÀڱؽÃÇè
  • minimal volition period
    ÃÖ¼Ò¼öÃà±â
  • functional residual air
    ±â´ÉÀûÀܱâ
  • residual abscess
    ÀÜ·ù°í¸§Áý, ÀÜ·ù³ó¾ç
  • residual accommodation
    ÀÜ¿©Á¶Àý
  • residual antigen
    ÀÜ¿©Ç׿ø
  • residual astigmatism
    ÀÜ¿©³­½Ã
  • coherent residual transverse magnetization
    °áÁýÀÜ·ù°¡·ÎÃàÀÚ±âÈ­
  • functional residual capacity
    ±â´ÉÀûÀܱâ¿ë·®
  • residual carbon
    ÀÜ¿©Åº¼Ò
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Alzheimers disease
    ¾ËÂêÇÏÀ̸Ӻ´.
  • American hookworm disease
    ¾Æ¸Þ¸®Ä«±¸Ã溴.
  • Aujeszkys disease virus
    ¿ÀÁ¦½ºÅ°º´¹ÙÀÌ·¯½º
  • B rgers disease
    ¹ö°Åº´.
  • Balos disease
    ¹ß·Îº´.
  • Bantis disease
    ¹ÝƼº´ ¡ì°£Á¾Ã¢¼º ºñÁ¾¡í.
  • Beards disease
    º£¾îµåº´=¼è¾àÁõÈıº(neurasthenia)
  • Beh ets disease
    º£Ã¼Æ®º´
  • Behcets disease
    º£¼¼Æ®º´
  • Behrs disease
    º£¸£º´
  • Bernard-Soulier disease
    º£¸£³ª¸£-¼ú¸®¿¡Áúȯ<--º´> ?
  • Bournevilles disease->tuberous sclerosis
    ºÎ¸£³×ºôº´
  • Bowens disease
    º¸À¢ º´
  • Brill-Zinsser disease
    ºê¸±-Áø¼­ Áúȯ
  • Brill-Zinsser disease
    ºê¸±-Áø¼­º´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • minimal effective analgesic concentration
    ÃÖ¼ÒÈ¿°úÀûÁøÅë³óµµ
  • minimal effective dose
    ÃÖ¼ÒÀ¯È¿·®.
  • minimal enhancement
    ¹Ì¹ÌÇÑ Á¶¿µÁõ°­, °æµµÀÇ Á¶¿µÁõ°­
  • minimal erythema dose
    ÃÖ¼ÒÈ«¹Ý·®(¡­ûõÚèåÖ).
  • minimal erythema dose
    ÃÖ¼ÒÈ«¹Ý·®(¡­ûõÚèåÖ)
  • minimal essential medium
    Ãּұ⺻¹èÁö
  • minimal identifiable odor
    ÃÖ¼ÒºÐÇØÃë°¢.
  • minimal identifiable odor
    ÃÖ¼ÒºÐÇØÃë°¢
  • minimal infecting dose
    ÃÖ¼Ò°¨¿°·®(õÌá³ÊïæøåÖ).
  • minimal lethal dose
    ÃÖ¼ÒÄ¡»ç·®(õÌá´öÈÞÝåÖ).
  • minimal lethal dose
    ÃÖ¼ÒÄ¡»ç·®(̧ËÛ̬Ë×Ëâ).
  • minimal lethal dose
    ÃÖ¼ÒÄ¡»ç·®(õÌá³öÈÞÝåÖ).
  • minimal nerve excitability test =NET
    ÃּҽŰæÀڱذ˻ç
  • minimal phototoxicity dose
    ÃÖ¼Ò±¤µ¶·®
  • minimal separable acuity
    ÃÖÀúºÐÇØ´É.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cytogenetic disease
    ¼¼Æ÷À¯ÀüÁúȯ(á¬øàë¶îîòðü´)
  • deficiency disease
    °áÇÌ Áúȯ(ÌÀù¹òðü´)
  • Fabry's disease
    ÆÄºê¸® Áúȯ (òðü´)
  • Farber's disease
    ÆÄ¾Æ¹ö Áúȯ(òðü´)
  • Forbe`s disease
    Æ÷ºê Áúȯ(òðü´)
  • Gaucher's disease
    °í¿À¼Å Áúȯ(òðü´)
  • genetic disease
    À¯Àü Áúȯ(ë¶îîòðü´)
  • Gilbert's disease
    ±æ¹öÆ® Áúȯ(òðü´)
  • glycogen storage disease
    ±Û¶óÀÌÄÚÀü ÀúÀå Áúȯ(îÍíúòðü´)
  • Hartnup's disease
    ÇÏÆ®³Ò Áúȯ(òðü´)
  • heavy-chain disease
    Áß(ñì)»ç½½ Áúȯ(òðü´)
  • Hers' disease
    ¿¡¸£½º Áúȯ(òðü´)
  • I-cell disease
    I-¼¼Æ÷ Áúȯ(á¬øàòðü´)
  • immune deficincy disease
    ¸é¿ª °áÇÌ Áúȯ(Øóæ¹ÌÀù¹òðü´)
  • Krabbe's disease
    Å©¶óº£Áúȯ(òðü´)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • collagen disease
    ±³¿øÁúº´
  • communicable disease
    Àü¿°º´
  • constitutional disease
    üÁú¼ºÁúȯ
  • coronary heart disease
    °ü»óµ¿¸Æ½ÉÁúȯ
  • Crohn's disease
    Å©·Ðº´
  • Crouzon's disease
    µÎ°³¾È¸éȸ°ñºÎÀüÁõ, Å©·çÁ¸º´
  • cyanotic heart disease
    û»ö¼º½ÉÀåÁúȯ
  • degenerative joint disease
    ÅðÇ༺°üÀýÁúȯ
  • demyelinating disease
    Å»¼öÃʼºÁúȯ
  • disease
    º´, Áúº´, Áúȯ
  • endemic disease
    Áö¹æº´, dzÅ亴
  • endocrine disease
    ³»ºÐºñÁúȯ
  • focal disease
    ÃÊÁ¡¼ºÁúȯ
  • glycogen storage disease
    ±Û¸®ÄÚ°Õ ÃàÀûÁúȯ
  • granulomatous disease
    À°¾ÆÁ¾¼ºÁúȯ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MCD magnetic circular dichroism; mast-cell degranulation; mean cell diameter; mean of consecutive differ...
LCP Disease Legg-Calve-Perthes Disease
  ? Stages of LCP Disease(= Juvenile Idiopathic AVN)
&nb...
AD accident dispensary; acetate dialysis; active disease; acute dermatomyositis; addict, addiction; ade...
PD Doctor of Pharmacy; Dublin Pharmacopoeia; interpupillary distance; Paget disease; pancreatic duct; p...
RD radial deviation; radiology department; rate difference; Raynaud disease; reaction of degeneration; ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
RV Residual Volume
RVF Residual Volume Fraction
ROFA Residual oil fly ash
RRF Residual renal function
PVR post void residual
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • residual pulp
    Àܼö
  • residual ridge crest
    ÀÜÁ¸ Ä¡Á¶´É
  • residual root
    ÀܱÙ
  • residual shrinkage
    ÀÜ·ù À§Ãà
  • residual stress
    ÀÜ·ù ÀÀ·Â, ÀÜ¿© ÀÀ·Â
    Àη¹ÀÌ ³³Çü Á¦ÀÛ ½Ã ³³ °¡¿­ÀÌ ºÎÁ·ÇϹǷΠÀÎÇØ Àη¹ÀÌ ¿Íµ¿¿¡ ¾ïÁö·Î ¾ÐÀÔÇÏ°Ô µÇ´Âµ¥ À̶§ ¾Ð·ÂÀ» ¸¹ÀÌ ¹ÞÀº ºÎºÐ¿¡ Àû°Ô ¹ÞÀº ºÎºÐº¸´Ù ÀÜÀ¯ ÀÀ·ÂÀÌ Á¸ÀçÇÔÀ¸·Î¼­ ³³ÇüÀÇ º¯ÇüÀ» ÃÊ·¡ÇÒ ¼ö°¡ ÀÖ´Ù.
  • residual urine
    ÀÜ´¢
  • kufs's disease °¡Á·¼º Èæ³»À强 ¹éÄ¡ÀÇ ¸¸¹ß¼º ¿¬¼ÒÇüÀÌ´Ù.

    Kugelberg-Welander disease ±Ù À§ÃàÁõÀÇ À¯Àü¼º ¿¬¼ÒÇüÀ¸·Î¼­ º¸Åë »ó¿°»öü¼º ¿­¼º ÇüÁú·Î À¯ÀüµÈ´Ù. ô¼ö Àü°¢ÀÇ º´º¯ÀÌ ±× ¿øÀÎÀÌ´Ù.

    kukuruku ¿øÀÎ ºÒ¸íÀ̸ç, ³ªÀÌÁö¸®¾Æ¿¡¼­ º¼ ¼ö ÀÖ´Â ÁúȯÀ¸·Î, ¿­

    °£Àå ´ë½Ä ¼¼Æ÷
  • Acosta's disease
    ¾ÆÄÚ½ºÅ¸º´
    µ¿ÀǾî=acute mountain sickness.
  • acquired cystic disease
    ÈÄõ¼º ³¶¼º Áúȯ
  • acquired heart disease
    ÈÄõ¼º ½É Áúȯ
    »ýÈÄ¿¡ ¾ò¾îÁø ½ÉÀå Áúȯ.
  • acute demyelinating disease
    ±Þ¼º Å»¼öÃʼº Áúȯ
  • acute infectious disease
    ±Þ¼º Àü¿°º´
    ¹ßº´ ÈÄ ¼öÀÏ- ¼öÁÖÀÏ·Î Ä¡À¯ ¶Ç´Â »ç¸ÁÇÏ´Â Àü¿°º´. ¾ö¹ÐÇÏ°Ô ±Þ¼º°ú ¸¸¼ºÀ» ±¸º°ÇÒ ¼ö ¾ø´Âµ¥, ÀϹÝÀûÀ¸·Î ¿¬±¸, ´ëÃ¥ÀÇ ÆíÀÇ»ó ºÐ·ùµÈ´Ù. ±Þ¼º Àü¿°º´Àº Áßµ¶ÀÏ °æ¿ì »ç¶÷µéÀÇ ÁÖ¸ñÀ» ¹Þ±â ½±°í, ¿¬±¸, ´ëÃ¥µµ ½Ç½ÃÇϱ⠽±´Ù. ÄÝ·¹¶ó, Æä½ºÆ®, µÎâ, Æú¸®¿À µîÀÌ ±×°ÍÀÌ´Ù. ÇÑÆí °æÁõÀÎ °ÍÀº ±×´ÙÁö Áß¿ä½Ã µÇÁö ¾Ê±â ¶§¹®¿¡ ¿¬±¸, ´ëÃ¥µµ ´Ê¾îÁö°í ÀÖ´Â °ÍÀÌ ¸¹´Ù. ÀÎÇ÷翣ÀÚ, È«¿ª, ¼öµÎ µîÀÌ ±× ¿¹ÀÌ´Ù.
  • adipose tissue disease
    Áö¹æ Á¶Á÷ Áúȯ
  • adrenal cortex disease
    ºÎ½Å ÇÇÁú Áúȯ
    ºÎ½Å ÇÇÁúÀÇ ±â´ÉÀå¾Ö·Î ÀÎÇØ »ý±ä º´. ±â´É ÀúÇÏ·Î ÀÎÇØ¼­´Â ¿¡µð½¼¾¾ º´
  • adult celiac disease
    ¼ºÀÎÇü ¼¿¸®¾ÆÅ©
    Áö¹æº¯ÁõÀÇ ¼ºÀκ´ ¶Ç´Â ºñ¿­´ë¼º ½ºÇÁ·ç¿ì.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
residual Remaining or left behind.
Origin: L. Residuus
(18 Nov 1997)
residual abscess An abscess recurring at the site of a former abscess resulting from persistence of microbes and pus.
(05 Mar 2000)
residual affinity Secondary forces that enable apparently saturated atoms, ions, or molecules to attract other atoms or groups, causing such phenomena as complex formation, hydration, adsorption, etc.
(05 Mar 2000)
residual air The volume of air remaining in the lungs at the end of a maximal expiration. Common abbreviation is rv.
(12 Dec 1998)
residual body 1. <cell biology> Secondary lysosomes containing material that cannot be digested.
2. <biology> The surplus cytoplasm shed by spermatids during their differentiation to spermatozoa. Usually the cytoplasm from several spermatids connected by cytoplasmic bridges.
3. <microbiology> Surplus cytoplasm containing pigment and left over after production of merozoites during schizogony of malaria parasites.
(18 Nov 1997)
residual body of Regaud The excess cytoplasm that separates from the spermatozoon during spermiogenesis.
(05 Mar 2000)
residual capacity The volume of air remaining in the lungs at the end of a maximal expiration. Common abbreviation is rv.
(12 Dec 1998)
residual cleft The remnants of the pituitary diverticulum that occur between the pars distalis and pars intermedia; a distinct lumen is present in some animals, but, in humans, is present only during prenatal development and sometimes in young children.
Synonym: residual lumen.
(05 Mar 2000)
residual cyst The persistence of an apical periodontal cyst that remains after tooth extraction.
(05 Mar 2000)
residual error The estimated discrepancy between the actual measured datum and the value for that value computed after a model has been fitted to the set of the data by an estimator.
(05 Mar 2000)
residual inhibition The inhibition or suppression of tinnitus by use of a sound-generating device (residual inhibitor) which masks the sounds of tinnitus and produces a residual sound-inhibiting effect when the device is turned off.
(05 Mar 2000)
residual inhibitor A sound-generating device, worn in the ear, which inhibits or suppresses the sounds of tinnitus by masking, with a residual inhibitory effect when the device is turned off.
(05 Mar 2000)
residual lumen The remnants of the pituitary diverticulum that occur between the pars distalis and pars intermedia; a distinct lumen is present in some animals, but, in humans, is present only during prenatal development and sometimes in young children.
Synonym: residual lumen.
(05 Mar 2000)
residual ovary syndrome <syndrome> The development of a pelvic mass, pelvic pain, and occasionally dyspareunia following hysterectomy without removal of both ovaries.
(05 Mar 2000)
residual ridge That portion of the processus alveolaris remaining in the edentulous mouth following resorption of the section containing the alveoli.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • residual security
    ÀÜ¿© Áõ±Ç(º¸Åë ÁÖ³ª Àüȯ »çä)
  • residual sovereignty
    ÀáÀç ÁÖ±Ç
  • disease
    º´,Áúȯ
  • Creutzfeldt-Jakob disease
    Å©·ÎÀÌÃ÷ÆçÆ®¾ßÄߺ´
  • DUST DISEASE
    =PNEUNOCONIOSIS
  • Dutch elm disease
    (½Ä)¼¼±Õ¼ºÀÇ ´À¸¨³ª¹«º´
  • English disease
    ¿µ±¹º´(³ëµ¿ÀÚÀÇ Å¾÷¿¡ ÀÇÇÑ »ý»ê ÀúÇÏ µîÀÇ »çȸÀû º´Æó);(°í)±¸·çº´;±â°üÁö¿°
  • Fabry's disease
    ÆÄºê¸®º´(¼±Ãµ¼º ÁöÁú ´ë»ç ÀÌ»óÁõ)
  • GVH disease
    ´ë¼÷ÁÖ¼º ÀÌ½ÄÆíº´
  • Graves' disease
    ±×·¹À̺êÁî(¹ÙÁ¦µµ)º´
  • Hansens disease
    ÇѼ¾º´;¹®µÕº´
  • Hashimoto's disease
    ÇϽø𵵺´;¸¸¼º °©»ó¼±¿°(°©»ó¼± ±â´ÉÀÌ ÀúÇϵǴ Áúȯ)
  • Hodgkin's disease
    È£ÁöŲ º´(¾Ç¼º À°¾ÆÁ¾Áß)
  • Marburg disease
    ¸¶¸£ºÎ¸£Å©º´(°í¿­,ÃâÇ÷ µ¿¹Ý)
  • Newcastle disease
    ´ºÄ³½½º´(¼³»ç,È£Èí °ï¶õÀ» ÁÖ·Î ÇÏ´Â ¹ÙÀÌ·¯½º¼º °¡±Ýº´)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á